Shaunak Deepak has joined H.C. Wainwright as a managing director and senior biotechnology analyst in the firm’s equity research group.
Mr. Deepak previously was a VP and biotech analyst with Jefferies since 2009. He also has been an associate in the life sciences equity research departments of Piper Jaffray, Rodman & Renshaw and Stifel, Nicolaus.
In a statement, CEO, Mark Viklund, said Mr. Deepak’s addition as HCW’s eighth senior biotech analyst further strengthens the firm’s position as a leading voice in the investment community on the life sciences sector.
